Karen Smith
Directeur/Membre du Conseil chez EMYRIA LIMITED
Fortune : 219 745 $ au 30/04/2024
Profil
Le Dr Karen L. Smith est médecin en chef chez Emergent BioSolutions, Inc. et directrice indépendante chez Antares Pharma, Inc. et Sangamo Therapeutics, Inc. et directrice indépendante chez Acceleron Pharma, Inc. Elle est membre du conseil d'administration d'Antares Pharma, Inc. et de Sangamo Therapeutics, Inc. et d'Acceleron Pharma, Inc. Le Dr Smith a été précédemment employée en tant que présidente et directrice générale de Medeor Therapeutics, Inc. et directrice générale d'Eliminate Cancer, Inc. et directrice et vice-présidente de Celator Pharmaceuticals, Inc, directeur non exécutif chez Forward Pharma A/S, directeur médical et vice-président exécutif de la recherche et du développement chez Jazz Pharmaceuticals Plc, vice-président principal des affaires médicales mondiales et chef de la dermatologie chez Allergan, Inc., chef des relations médicales externes chez AstraZeneca LP, chef des opérations cliniques aux États-Unis chez Bristol Myers Squibb Co. et directeur général chez Boron Molecular Ltd. Elle a également siégé au conseil d'administration de Sucampo Pharmaceuticals, Inc. Elle a obtenu un diplôme de premier cycle à l'université de technologie de Curtin, un diplôme d'études supérieures à l'université de Salford, un MBA à l'université de New England (Australie), un doctorat à l'université de Warwick et un doctorat à l'université de Western Australia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 194 690 ( 0,45% ) | 200 531 $ | 30/04/2024 | |
| 08/04/2024 | 38 200 ( 0,02% ) | 19 215 $ | 30/04/2024 | |
| 18/08/2023 | 0 ( -.--% ) | - $ | 30/04/2024 | |
-.--% | 13/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Karen Smith
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/06/2018 |
| EMYRIA LIMITED | Directeur/Membre du Conseil | 29/11/2021 |
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 18/08/2023 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Directeur/Membre du Conseil | - |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Directeur Technique/Scientifique/R&D | - |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Directeur/Membre du Conseil | 08/03/2022 |
Anciens postes connus de Karen Smith
| Sociétés | Poste | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| ANTARES PHARMA, INC. | Directeur/Membre du Conseil | 24/05/2022 |
| ACCELERON PHARMA INC. | Directeur/Membre du Conseil | 19/11/2021 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Karen Smith
| University of Warwick | Doctorate Degree |
| The University of Western Australia | Doctorate Degree |
| University of New England (Australia) | Masters Business Admin |
| University of Salford | Graduate Degree |
| Curtin University of Technology | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| EMYRIA LIMITED | Technology Services |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Boron Molecular Ltd. manufactures fine chemicals. Its products include biaryls, boronic acid esters and acids, catalyst, cubanes, diborons, energy storage, halides, polymer, raft agents, and trifluoroborates. The company was founded in 2001 and is headquartered in Noble Park, Australia. | Process Industries |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
| Eliminate Cancer, Inc. | |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Health Technology |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Commercial Services |
